ozempic semaglutide weight loss off-label and Wegovy worldwide shortage due to use for cosmetic How to Qualify for Ozempic

Medical Weight Loss at a Glance EXPECTED RESULTS Sustainable fat loss, increased energy, appetite control, improved metabolic function, and reduced inflammation TREATMENT LENGTH Initial consult + ongoing weekly or biweekly check-ins

Individuals who may warrant closer monitoring include: Those with a personal or family history of depression , anxiety, or other mood disorders People who have previously experienced mood changes on other weight-loss medications or GLP-1-based therapies Individuals with eating disorders or a complex relationship with food , for whom appetite suppression may have psychological implications (see NICE guideline NG69: Eating disorders: recognition and treatment) [10] Those experiencing significant life stressors alongside starting a new treatment People with poorly controlled type 2 diabetes , where fluctuating blood glucose levels both hypoglycaemia and hyperglycaemia can independently affect mood, concentration, and emotional wellbeing It is also worth acknowledging that obesity itself is associated with higher rates of depression and anxiety, and that the psychological experience of rapid body weight change whether positive or negative can be emotionally complex

As previously mentioned, two GLP-1 RAs are available for the management of weight even in patients who do not have diabetes [33, 34]

If you have questions about GLP-1 medications or want to explore your options, check out our FAQs

What you should notice: some appetite reduction, possibly different from what semaglutide produced